BeStock  
Stocks › Biotechnology › ORIC

Oric Pharmaceuticals ORIC

US equityMarket cap rank #3332Biotechnology
$7.36 −$0.34 (-4.42%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $7.37 +0.14%
Open$7.58
Prev close$7.70
Day range$7.28 – $8.00
Volume1.46M
Market cap$764.94M
P/E (TTM)–
Dividend yield–

Earnings

QuarterReport dateTimingImplied moveActual moveVersus implied
2021/Q421 Mar 2022After Market–-28.74%–
2020/Q25 Aug 2020After Market–+14.07%–

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Latest reported quarter: Q2, ended Jun 2026

Revenue$0.00
Operating profit-$45.30M-16.0% YoY
Net profit-$41.49M-14.1% YoY
Diluted EPS-$0.38+19.1% YoY
Free cash flow-$31.96M-3.4% YoY
Operating cash flow-$31.61M

Revenue, last 8 quarters

$0.0Sep '24$0.0Dec '24$0.0Mar '25$0.0Jun '25$0.0Sep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26

Net profit, last 8 quarters

$-34.6MSep '24$-36.3MDec '24$-30.0MMar '25$-36.4MJun '25$-32.6MSep '25$-30.5MDec '25$-35.8MMar '26$-41.5MJun '26

Profitability & balance sheet

Return on equity-39.8%
Return on assets-37.4%
Return on invested capital-39.4%
Current ratio13.19
Liabilities / assets5.8%
Cash & investments$264.76M
Net cash (debt)$264.76M

Discussion

No comments yet — be the first to weigh in on ORIC.

Sign in to join the discussion.

Scroll to Top